News
Click here to subscribe to our news updates
Select year:
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016
Click here for announcements regarding managers transactions.
Click here for news in Danish.
October 28, 2025 | Press Releases
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of VaccinesJuly 22, 2025 | Press Releases
Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya VaccineJune 26, 2025 | Press Releases
Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women June 12, 2025 | Press Releases
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in ChildrenMay 02, 2025 | Press Releases
Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United KingdomMarch 07, 2025 | Press Releases
Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and OlderFebruary 25, 2025 | Press Releases
Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine December 16, 2024 | Press Releases
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India October 29, 2024 | Press Releases
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine